ACE2, the SARS-CoV-2 receptor,has been identified on glial cells and neurons in the human brain.SARS-CoV-2 neurotropism can occur through circulation and/or an uppernasal transcribrial pathway that allows COVID-19 to reach the brainand to bind and engage with ACE2 receptors. This evidence concerns the gene ACE2 and COVID-19.